Ritholtz Wealth Management Pro Phase Labs, Inc. Transaction History

Ritholtz Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 14, 2023	SELL	$7.15 - $9.78 $15,880 - $21,721	-2,221 Reduced 8.67%	23,390 $169,000
Q1 2023 Apr 19, 2023	SELL	$6.62 - $9.57 $2,866 - $4,143	-433 Reduced 1.66%	25,611 $195,000
Q4 2022 Jan 18, 2023	BUY	$8.78 - $12.47 $47,131 - $66,938	5,368 Added 25.96%	26,044 $0
Q3 2022 Oct 18, 2022	BUY	$8.96 - $14.7 $185,256 - $303,937	20,676 New	20,676 $233,000

1.71M

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $10.1M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

Get notified when there are updates to the investment portfolio of Ritholtz Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Ritholtz Wealth Management with notifications on news.